RVNC – revance therapeutics, inc. (US:NASDAQ)
Stock Stats
News
1/3
06:20 pm
rvnc
Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Revance Therapeutics, Inc. and Certain Officers -RVNC
12/28
02:12 am
rvnc
Low
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/23
02:59 pm
rvnc
Low
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, USAP, NBR on Behalf of Shareholders
12/23
08:00 am
rvnc
Low
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its price target lowered by analysts at Barclays PLC from $7.00 to $3.00. They now have an "equal weight" rating on the stock.
12/20
02:03 am
rvnc
Low
Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
8/8/2024
04:05 pm
RVNC
19.7%
BEAT
5/9/2024
04:06 pm
RVNC
-22.6%
BEAT
2/28/2024
04:05 pm
RVNC
26.1%
BEAT
12/23
07:42 am
Maintains
Equal-Weight
Equal-Weight
Barclays
Low
1.0%
12/23
07:42 am
Maintains
Equal-Weight
Equal-Weight
Barclays
Low
1.0%
12/10
08:08 am
Maintains
Neutral
Neutral
Mizuho
Low
0.2%
12/10
08:08 am
Maintains
Neutral
Neutral
Mizuho
Low
0.2%
11/8
01:44 pm
Reiterates
Hold
Needham & Company LLC
Medium
4.4%
1/3
04:34 pm
rvnc
Neutral
Form 4 Revance Therapeutics, For: Dec 31 Filed by: Schilke Tobin
1/3
04:34 pm
rvnc
Neutral
Form 4 Revance Therapeutics, For: Dec 31 Filed by: Foley Mark J
1/2
04:45 pm
rvnc
Low
Form SC TO-T/A Revance Therapeutics, Filed by: Crown Laboratories, Inc.
1/2
04:37 pm
rvnc
Low
Form SC 14D9/A Revance Therapeutics, Filed by: Revance Therapeutics, Inc.
12/19
09:01 am
rvnc
Low
Form SCHEDULE 13D/A Revance Therapeutics, Filed by: Teoxane SA
Show more
Top News Gainers
1/9 Revance to Participate in the 38th Annual J.P. Morgan Healthcare Conference 18.3%
5/9 Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 16.5%
10/14 Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne 15.1%
4/2 Revance Therapeutics Inc (NASDAQ: RVNC) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.4%
12/2 Revance Therapeutics Inc (NASDAQ: RVNC) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating and a $25.00 price target on the stock. 8.2%
1/11 Did Changing Sentiment Drive Revance Therapeutics's (NASDAQ:RVNC) Share Price Down By 25%? [Yahoo! Finance News] 7.7%
8/8 Revance Therapeutics Inc (NASDAQ: RVNC) had its "outperform" rating re-affirmed by analysts at William Blair. 7.2%
1/15 Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. 5.3%
10/15 Form 8-K Revance Therapeutics, For: Oct 11 4.7%
7/29 Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019 4.6%
Top News Decliners
4/1 Revance Therapeutics Inc (NASDAQ: RVNC) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $35.00 price target on the stock. -14.9%
12/3 Revance Announces Proposed Public Offering of Common Stock -14.6%
3/17 Form 4 Revance Therapeutics, For: Mar 15 Filed by: Joshi Abhay -13.7%
3/13 Form SC 13G Revance Therapeutics, Filed by: GIC Private Ltd -12.0%
2/25 Revance Therapeutics Inc (NASDAQ: RVNC) had its price target raised by analysts at Needham & Company LLC from $32.00 to $36.00. They now have a "buy" rating on the stock. -9.6%
2/10 Form 8-K Revance Therapeutics, For: Feb 10 -9.2%
4/15 Revance Therapeutics Inc (NASDAQ: RVNC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock. -7.3%
2/26 Form 10-K Revance Therapeutics, For: Dec 31 -7.2%
4/30 Revance to Release First Quarter 2020 Financial Results on Thursday, May 7, 2020 -6.5%
8/27 Form 8-K Revance Therapeutics, For: Aug 22 -6.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3